Clinical Trial Update: Avastin and Tarceva for Upper Gastrointestinal Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating the combination of Avastin (bevacizumab) and Tarceva (erlotinib) for cholangiocarcinoma and gallbladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Cholangiocarcinoma, Gallbladder Cancer | Phase 2 | Status: COMPLETED